James H. Heal & Company Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
James H. Heal & Company Limited - overview
Established
1872
Location
-, -, UK
Primary Industry
Industrial Machinery
About
James H. Heal & Company Limited is a specialized manufacturer of textile testing instruments, providing essential solutions for accurate assessment in the textile industry, ensuring quality and performance through advanced technologies. Founded in 1872 in the UK, James H. Heal & Company Limited focuses on developing and manufacturing textile testing instruments.
The company was acquired by Physical Properties Testing, a portfolio company of Battery Ventures, in September 2014. The company does not have any known subsidiaries or parent companies. James Heal specializes in textile testing instruments and materials, offering a wide range of products designed to ensure precise and reliable results for the textile industry. Their core product offerings include universal testing machines, bursting strength testers, flammability testers, and various performance testers such as air permeability and moisture management testers.
These instruments are engineered to assess crucial textile properties, including tensile strength, tear resistance, and flammability, addressing the needs of manufacturers and laboratories across diverse applications. The company serves a global clientele, including over 1,000 laboratories in sectors ranging from apparel to industrial textiles, primarily in markets across Europe, North America, and Asia. By providing high-performance consumables and integrated software solutions like TestWise™ OS, James Heal enhances testing efficiency and accuracy, positioning itself as a trusted partner in textile quality assurance. In the most recent year, 2023, James Heal reported a revenue of USD 28.
64 mn and an EBITDA of USD 4. 33 mn. The company generates revenue through direct sales of its textile testing instruments and consumables to laboratories and manufacturers, employing a B2B transaction model. The revenue structure is characterized by one-time purchases of testing machines and materials, supplemented by ongoing service and calibration contracts that ensure instrument performance over time.
James H. Heal is actively pursuing the development of new textile testing instruments to address emerging industry needs, with anticipated launches scheduled for late 2024. The company aims to expand its reach into key markets in South America and Africa by 2025, seeking to capitalize on the increasing demand for textile quality assurance in these regions. The acquisition by Physical Properties Testing in September 2014 has positioned James Heal to leverage additional resources for these initiatives.
Current Investors
Physical Properties Testers Group
Primary Industry
Industrial Machinery
Sub Industries
Industrial Machinery
Website
www.james-heal.co.uk
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
James H. Heal & Company Limited - financials
| Fiscal Year Ended | Oct 31, 2010 | Oct 31, 2011 | Oct 31, 2012 | Oct 31, 2013 | Oct 31, 2014 | Oct 31, 2015 | Oct 31, 2016 | Oct 31, 2017 | Oct 31, 2018 | Oct 31, 2019 | Oct 31, 2020 | Oct 31, 2021 | Oct 31, 2022 | Oct 31, 2023 | Oct 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 7,756,001 | 9,251,866 | 9,789,343 | 10,179,250 | 10,939,711 | 12,050,752 | 13,041,889 | 14,121,848 | 14,302,941 | 13,972,599 | 10,974,644 | 13,014,926 | - | - | - |
| % Revenue Growth (YoY) | - | 19.3% | 5.8% | 4.0% | 7.5% | 10.2% | 8.2% | 8.3% | 1.3% | (2.3%) | (21.5%) | 18.6% | - | - | - |
| EBITDA (USD) | 797,367 | 847,536 | 852,203 | 901,003 | 1,162,386 | 1,787,806 | 2,264,259 | 2,940,491 | 2,796,859 | 3,276,972 | 1,798,316 | 2,597,291 | - | - | - |
| Operating Income (USD) | 594,149 | 648,986 | 694,881 | 736,073 | 978,624 | 1,585,174 | 2,035,232 | 2,754,783 | 2,647,552 | 3,147,780 | 1,700,759 | 2,498,942 | - | - | - |
| Operating Margin | 7.7% | 7.0% | 7.1% | 7.2% | 8.9% | 13.2% | 15.6% | 19.5% | 18.5% | 22.5% | 15.5% | 19.2% | - | - | - |
| % EBITDA Margin | 10.3% | 9.2% | 8.7% | 8.9% | 10.6% | 14.8% | 17.4% | 20.8% | 19.6% | 23.5% | 16.4% | 20.0% | - | - | - |
| NET Income (USD) | 491,834 | 601,205 | 705,644 | 658,504 | 888,495 | 1,338,479 | 1,688,697 | 2,264,801 | 2,104,157 | 2,763,211 | 1,539,163 | 2,161,128 | - | - | - |
| % Net Margin | 6.3% | 6.5% | 7.2% | 6.5% | 8.1% | 11.1% | 12.9% | 16.0% | 14.7% | 19.8% | 14.0% | 16.6% | - | - | - |
James H. Heal & Company Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | James H. Heal & Company Limited | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.